GREEN BAY, WI — David Novak, a patient at the Hemophilia Outreach Center, made history as the first Wisconsinite — and only the second person in the nation — to receive the newly FDA-approved gene therapy treatment ROCTAVIAN for hemophilia A. This breakthrough offers hope for reducing or eliminating the need for regular infusions and marks a major milestone for the hemophilia community.
Procedures and Bleeding Disorders: When to Contact Your HTC with Kristin Petrie
Today on Beyond the Bleeds, Heather and John are joined by Kristin Petrie, HOC Nurse Coordinator, to talk about what people with bleeding disorders should know before their next procedure and why contacting your Hemophilia Treatment Center ahead of time is so...

